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Abstract
Background: B-lines evaluated by lung ultrasound (LUS) are the sonographic sign of pulmonary congestion, a
major predictor of morbidity and mortality in patients with heart failure (HF). Our aim was to assess the prognostic
value of B-lines at discharge to predict rehospitalization at 6 months in patients with acute HF (AHF).
Methods: A prospective cohort of 100 patients admitted to a Cardiology Department for dyspnea and/or clinical
suspicion of AHF were enrolled (mean age 70 ± 11 years). B-lines were evaluated at admission and before discharge.
Subjects were followed-up for 6-months after discharge.
Results: Mean B-lines at admission was 48 ± 48 with a statistically significant reduction before discharge (20 ± 23,
p < .0001). During follow-up, 14 patients were rehospitalized for decompensated HF. The 6-month event-free survival
was highest in patients with less B-lines (≤ 15) and lowest in patients with more B-lines (> 15) (log rank
χ2 20.5, p < .0001). On multivariable analysis, B-lines > 15 before discharge (hazard ratio [HR] 11.74; 95 % confidence
interval [CI] 1.30–106.16) was an independent predictor of events at 6 months.
Conclusions: Persistent pulmonary congestion before discharge evaluated by ultrasound strongly predicts
rehospitalization for HF at 6-months. Absence or a mild degree of B-lines identify a subgroup at extremely low risk to
be readmitted for HF decompensation.
Keywords: Lung ultrasound, B-lines, Ultrasound lung comets, Pulmonary congestion, Prognosis,
Rehospitalization
Introduction
Heart failure (HF) afflicts 1–2 % of people in the western
world, with an incidence of 5–10 per 1000 persons per year
[1]. Acute heart failure (AHF) is the most common reason
for hospitalization in patients aged > 65 years [2, 3]. Despite
significant improvement in signs and symptoms during
hospitalization, post-discharge outcomes for patients hospi-
talized for AHF are poor. Up to 25 % of AHF patients are
readmitted within 30 days of discharge, with a high mortal-
ity rate during this period [4].
Pulmonary congestion is a major predictor of morbid-
ity and mortality in HF [5]. It is the single most import-
ant contributor to hospitalization, more significant than
a low cardiac output [6]. Congestion is often not ad-
equately addressed during hospitalization; patients ex-
perience improved symptoms, and may be free of
clinical congestion but have persistent hemodynamic or
pulmonary congestion [5, 7–9]. Failure to adequately re-
lieve congestion during hospitalization is associated
with increased morbidity and mortality, whereas pa-
tients discharged without congestion show better out-
comes [10, 11].
Lung ultrasound (LUS) is a simple, accurate, and
patient-friendly tool to assess pulmonary congestion, by
evaluation of B-lines (previously called ultrasound lung
comets) [12, 13]. B-lines are the sonographic sign of the
pulmonary interstitial syndrome, representing the pul-
monary interstitial edema in patients with AHF. Many
studies have shown their utility in the differential diag-
nosis of acute dyspnea [14–20]. As such, assessment of
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B lines is now recommended in the pre-hospital and
hospital management of AHF, as a bedside tool to en-
able direct visualization of interstitial edema in patients
with suspected AHF [21]. Fewer studies are available on
the prognostic role of pulmonary congestion assessed
by B-lines, especially at discharge.
The aim of our study was to assess the prognostic
significance of pulmonary congestion at discharge, as
assessed by LUS B-lines, in patients admitted to a
Cardiology Department with a suspicion of AHF. The
study hypothesis is that in patients with detectable
LUS at discharge the rate of events during follow-up is
higher.
Methods
Patient population
A prospective cohort of 118 patients admitted to a
Cardiology Department at a single center were enrolled.
The inclusion criterion was the presence of signs and/or
symptoms of AHF, irrespective of the etiology. Exclusion
criteria were: 1) Inability to provide informed consent; 2)
Known history of pulmonary fibrosis, pneumothorax,
fibrothorax, lung cancer; 3) Patients not discharged
home, but transferred to another department. From the
initial population, 5 patients were excluded: 2 for known
pulmonary fibrosis (1 patient with systemic sclerosis and
1 patient with post-irradiation thoracic fibrosis), 1 for
fibrothorax, 1 for lung cancer, and 1 because she was
transferred to another department and not discharged
home.
The local Ethical Committee approved the protocol and
all patients gave informed consent. The study conforms to
the principles outlined in the Declaration of Helsinki.
Lung ultrasound
Experienced sonographers (cardiologists and technicians
accredited in transthoracic echocardiography by the
European Association of Cardiovascular Imaging) per-
formed the LUS examinations. LUS was performed twice
in all patients: the first evaluation was done at admission
at the end of standard echocardiography. The second
evaluation was performed before discharge at the end of
echocardiography, in case a second echocardiography
was requested by the attending physicians, or as stand-
alone examination. Patients were in the supine or near-
to-supine position. The ultrasound scanning of the an-
terior and lateral chest was obtained as previously de-
scribed on the right and left hemithoraxes. A detailed
video showing how to perform a LUS examination to
detect B-lines can be freely accessed at the following
link: http://www.youtube.com/watch?v=amsULL ws8GI.
A B-line was defined as a discrete laser-like vertical
hyperechoic reverberation artifact that arises from the
pleural line, extends to the bottom of the screen without
fading, and moves synchronously with lung sliding [12]. In
each intercostal space, the number of B-lines was recorded,
and the sum of B-lines of each scanning sites yielded a
score denoting the extent of the pulmonary interstitial
edema. Zero was defined as a complete absence of B-lines
in a scanning site. The presence of B-lines was staged in
three grades, according to previous literature [22]: mild
(a total of 6–15 B-lines on all scanning sites), moderate
(a total of 16–30 B-lines on all scanning sites), and
severe (> 30 B-lines on all scanning sites). The LUS ex-
aminations were performed with the same probe and
same setting routinely used for echocardiographic studies.
The intra- and interobserver variability of B-lines quantifi-
cation have been previously tested in our laboratory as 5.1
and 7.4 %, respectively [23, 24]. A high reproducibility has
been reported by other studies [25, 26].
Reference standard definition of heart failure
Two cardiologists, who were blinded to the results of
LUS evaluation, reviewed all the available medical re-
cords pertaining to the patient, and made an independ-
ent assessment of the probability of the patient having
HF. Confirmation of AHF was based on the Framing-
ham criteria, with corroborative information including
clinical diary, information on hospital course, response
to diuretics and other drugs, haemodynamic monitor-
ing, electrocardiograms, chest X-ray, echocardiography,
natriuretic peptides, and results of subsequent cardiac
testing, including nuclear medicine or magnetic reson-
ance imaging. For patients with a diagnosis other than
HF, confirmation was attempted using the following var-
iables: normal chest X-ray (lack of heart enlargement
and signs of pulmonary congestion), normal systolic and
diastolic heart function by echocardiography, normal
valve function at echocardiography, normal natriuretic
peptides, hospital clinical course. In cases when the two
cardiologists failed to agree on a diagnosis, a consensus
was reached with a third expert.
Follow-up data
Follow-up data were obtained from at least 1 of 4
sources: review of the patient's hospital record, personal
communication with the patient’s physician and review
of the patient’s chart, a telephone interview with the pa-
tient conducted by trained personnel, a staff physician
visiting the patients at regular intervals in the out-
patient clinic. According to study protocol, follow-up
information were obtained at 6 months. By inclusion
criteria, follow-up data were obtained in all patients.
Events were defined as rehospitalization for AHF in the
6 months following discharge. The development or
progression of HF was defined according to the same
criteria used for the reference standard definition of HF
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at admission. Patients who died were censored at the
time of death.
Statistical analysis
Continuous variables are expressed as mean ± SD. Two-
sample comparisons were performed using t-test if vari-
ables were normally distributed, the Mann–Whitney U test
for not normally distributed data, and the chi-squared test
for categorical data. Death rates were estimated with
Kaplan-Meier curves and compared by the log-rank test.
A sample size calculation established a number of 91
patients to get an alpha error of 0.05, and a power of 0.9.
The association of selected variables with outcome was
assessed with the Cox’s proportional hazard model using
univariable and stepwise multivariable procedures. A sig-
nificance of p<0.05 was required for a variable to be in-
cluded into the multivariable model, whilst p<0.1 was the
cut-off value for exclusion. The following covariates were
analysed at multivariable analysis: NYHA class, haemoglo-
bin, NT-proBNP at discharge, B-lines at admission and at
discharge. Hazard ratios (HR) with the corresponding 95 %
confidence interval (CI) were estimated. Statistical signifi-
cance was set at p < 0.05. All analyses were conducted with
the Statistical Package for the Social Sciences (SPSS Inc.,
Chicago, Illinois, version 20) and GraphPad Prism version 6
(GraphPad Software Inc., San Diego, CA, USA).
Results
Cardiopulmonary ultrasound
Nine patients were excluded, after blinded reclassification,
because of lack of signs and symptoms of HF. One patient
was excluded because of in-hospital death. Three patients
were lost at follow-up. Clinical characteristics of the final
study population of 100 patients are shown in Table 1 and
cardiac and lung ultrasound data are shown in Table 2.
Ejection fraction was < 50 % in 74 patients; a signifi-
cant diastolic dysfunction with restrictive pattern was
present in 23 patients; 15 patients had a severe mitral
regurgitation, 1 patient had a severe mitral stenosis, 3
patients had a severe aortic stenosis and 1 patient had a
severe aortic regurgitation. The main aetiology of HF
was coronary artery disease (52 patients), dilated
cardiomyopathy (18 patients), valvular heart disease
(15 patients), hypertensive heart disease (6 patients),
arrhythmias (5 patients), hypertrophic cardiomyopathy
(3 patients), chemotherapy-related cardiomyopathy
(1 patient).
LUS scanning was feasible in 100 % of the cases and time
needed for the examination was always less than 5 min.
Mean B-lines at admission was 48 ± 48 with a statistically
significant reduction before discharge (20 ± 23, p < .0001,
Fig. 1). In 27 % of patients with a severe degree of B-lines at
admission, the attending physician did not report pulmon-
ary crackles at physical examination.
Outcomes
The patient who died during hospitalization had a severe de-
gree of B-lines in the last LUS scanning, the same day of his
death. This patient was excluded from the analysis. During
the 6-month follow-up a total of 14 rehospitalization for HF
and 4 deaths occurred. Mean follow-up was 159 ± 50 days.
A ROC analysis was performed to identify > 50 B-lines
at admission as the best cut-off to predict readmission for
HF during follow-up with a sensitivity of 71.4 %, specifi-
city of 69.8 % negative predictive value of 93.7 %, positive
predictive value of 27.8 %, negative likelihood ratio of
0.41, positive likelihood ratio of 2.36 (area under the curve
0.71, 95 % confidence interval 0.58–0.85, p = .011). A ROC
Table 1 Clinical characteristics of the study population
Patients n = 100
Male (n, %) 73 (73 %)
Age (years) 70 ± 11
NYHA class 2.9 ± 0.9
SAP (mmHg) 126 ± 24
Diabetes Mellitus (n, %) 39 (39 %)
Hypertension (n, %) 57 (57 %)
Dyslipidemia (n, %) 39 (39 %)
Current smokers (n,%) 12 (12 %)
Creatinine (mg/dl) 1.3 ± 0.6
Hemoglobin (g/dl) 12.9 ± 2.1
CRP (mg/l) 1.4 ± 2
NT-proBNP (ng/l) 5291 ± 5877
NYHA New York Heart Association, SAP systolic arterial pressure, CRP
C-reactive protein
Table 2 Cardiac and pulmonary ultrasound data of the study
population
Ejection fraction (%) 37 ± 14
Wall motion score index 1.8 ± 0.56
LV end-diastolic diameter (mm) 58 ± 10
Impaired relaxation (n, %) 20 (20 %)
Pseudonormal pattern (n, %) 11 (11 %)
Restrictive pattern (n, %) 23 (23 %)
Moderate to severe mitral valve disease (n, %) 54 (54 %)
Moderate to severe aortic valve disease (n, %) 12 (12 %)
TAPSE (mm) 16.5 ± 4.7
PASP (mmHg) 49 ± 15
Pericardial effusion (n, %) 9 (9 %)
Pleural effusion (n, %) 24 (24 %)
B-lines at admission 48 ± 48
B-lines before discharge 20 ± 23
LV left ventricular, TAPSE tricuspid annular plane systolic excursion, PASP
pulmonary artery systolic pressure
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analysis was performed to identify > 15 B-lines at discharge
as the best cut-off to predict readmission for HF during
follow-up with a sensitivity of 92.9 %, specificity of 68.6 %
negative predictive value of 98.3 %, positive predictive value
of 32.5 %, negative likelihood ratio of 0.1, positive likelihood
ratio of 2.96 (area under the curve 0.83, 95 % confidence
interval 0.74–0.92, p < .0001). The 6-month event-free
survival showed a significantly better outcome for those
patients with ≤ 15 B-lines at discharge, whereas a worse
outcome was observed in patients with > 15 B-lines at
discharge (log rank χ2 20.5, p < .0001) (Fig. 2). Table 3
shows the parameters that were significantly different
between patients with and without events. Predictors of
HF hospitalization by univariate and multivariate ana-
lysis are reported in Table 4. At multivariable analysis,
only a number of B-lines > 15 before discharge was an
independent predictor of HF readmission at 6 months
(hazard ratio [HR] 11.74; 95 % confidence interval [CI]
1.30–106.16).
When considering a follow-up of 3 months, the same
cut-off of > 15 B-lines predicted readmission for HF with a
sensitivity of 100 % and specificity of 64.8 %. The ROC
analysis identified > 20 B-lines at discharge as the best cut-
off to predict readmission for HF at 3 months follow-up,
with a sensitivity of 100 %, a specificity of 74.7 %, negative
predictive value of 100 %, positive predictive value of
28.1 %, negative likelihood ratio of 0, positive likelihood
ratio of 3.96 (area under the curve 0.88, 95 % confidence
interval 0.81-0.96, p < .0001). Kaplan-Meier curves depict-
ing the prognostic value of > 20 B-lines before discharge at
a 3 months follow-up are shown in Fig. 3 (log rank χ2
22.96, p < .0001).
Discussion
In patients admitted with AHF to a cardiology depart-
ment, the absence of significant pulmonary congestion
before discharge, assessed by lung ultrasound, identifies
a subgroup at a very low risk of being readmitted for
decompensated HF in the following 6 months.
Pathophysiology of persistent congestion
The role of persistent congestion at hospital discharge
is relevant in the outcome of patients with AHF. The
early post-discharge time interval immediately after
hospitalization, which is often addressed to as the
Fig 1 Individuals dynamic changes in admission-to-discharge B-lines
Fig 2 Kaplan-Meier survival curves in HF patients stratified according to the number of B-lines before discharge, at 6-months follow-up
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vulnerable phase [27], has been recognized as a crucial
moment in the management of AHF, when the major-
ity of events occur [28, 29]. Patients with HF die or
are hospitalized for different reasons, including ische-
mia, arrhythmias, worsened hemodynamics. However,
in the vast majority the underlying pathophysiology is
primarily related to increasing left ventricular filling
pressures [30]. In the continuum of the congestion cas-
cade in HF, it is important to distinguish the different
phases of congestion [5, 31]: increased left ventricular fill-
ing pressures represent a phase of hemodynamic conges-
tion, which is different from pulmonary, and from
systemic and clinical congestion. In this cascade, pulmon-
ary congestion more specifically refers to extravascular lung
water (EVLW). Patients with the same degree of LV filling
pressures may have significantly different degrees of pul-
monary congestion, from complete absence of EVLW to al-
veolar pulmonary edema. These differences rely on many
aspects, which are often difficult to be assessed, including
the integrity of alveolar-capillary membrane – that depends
also on the length of the disease -, the systemic inflamma-
tion status which may influence vascular permeability, and
lymphatic drainage. LUS evaluation of B-lines offers a spe-
cific visualization of pulmonary congestion [32], thus eas-
ily allowing a non-invasive and bedside assessment of the
degree of EVLW in any single patient. This information
adds to the assessment of hemodynamic congestion
that can be non-invasively performed through echo-
Doppler parameters. Natriuretic peptides, which are
very useful at all steps of the management of HF pa-
tients, reflect more hemodynamic than pulmonary
congestion. This can explain why natriuretic peptides
and B-lines are somehow correlated in relatively large
populations [15], but can provide very different infor-
mation in the single patient, one enhancing the value
of the other, especially in patients with natriuretic
peptides in the grey zone [16, 17].
It is worth highlighting that there is no standardized
method to assess pulmonary congestion in the clinical
arena [5]. Chest X-ray is the most widely used tool to
establish the presence and degree of EVLW, allowing a
visualization of the lungs in the context of the whole
chest. However, both sensitivity and specificity to detect
signs of pulmonary congestion are suboptimal. Nearly
20 % of patients with HF have a normal chest X-ray,
limiting overall sensitivity [21, 33].
Comparison with previous studies
The search for an optimal tool to predict rehospitalization
for HF has been going on for years. Some scores have been
proposed, although predictive models of HF hospitalization
are still not currently implemented in the clinical practice.
Most scores have been validated on chronic HF in ambula-
tory outpatients, and include clinical, biochemical and
sometimes instrumental data, such as the HFPSI (Heart
Failure Patient Severity Index) [34], the CHARM score
[35], and more recently the REDIN score [36].
Previous studies have demonstrated the prognostic
role of B-lines as an independent predictor of events in
patients admitted with dyspnea and/or chest pain, in
acute coronary syndromes, in hemodialysis, and in
chronic HF even when assessed by a hand-held ultra-
sound device [37–41]. However, these analysis refer to
admission exams and not to discharge, when the clinical
information derived from a timely assessment can be
relevant not only in a population-based approach, but
also in a patient-based risk assessment, useful for man-
agement decisions, including discharge therapy, diuretic
dosage, follow-up timing.
Clinical implications
In the last few years the use of B-lines in the management
of patient with acute and chronic HF has moved from the
research setting to the clinical arena, and its assessment is
now included in Recommendation papers [21, 42, 43].
Table 3 Different parameters in patients with and without
events (HF readmission at 6 months)
No HF readmission
(n = 86)
HF readmission
(n = 14)
p
Male sex 62 (72 %) 11 (79 %) 0.61
Age (years) 70.3 ± 10.9 69.8 ± 0.51 0.87
NYHA class 2.7 ± 0.9 3.4 ± 0.9 0.02
SAP (mmHg) 126 ± 22 124 ± 140 0.79
Diabetes Mellitus (n, %) 31 (36 %) 8 (57 %) 0.14
Hypertension (n, %) 49 (58 %) 8 (57 %) 0.37
Creatinine (mg/dl) 1.3 ± 0.5 1.6 ± 1.2 0.09
Hemoglobin (g/dl) 13.0 ± 2.1 12.0 ± 2.4 0.10
CRP (mg/l) 1.4 ± 2.1 1.1 ± 1.3 0.56
NT-proBNP (ng/l) at
admission
5091 ± 5929 6203 ± 5821 0.57
NT-proBNP (ng/l) at
discharge
3065 ± 4103 3816 ± 2764 0.09
Ejection fraction (%) 37 ± 13 37 ± 19 0.99
Wall motion score index 1.85 ± 0.57 1.83 ± 0.68 0.88
Restrictive pattern (n, %) 22 (26 %) 1 (7 %) 0.25
TAPSE (mm) 16.8 ± 4.7 14.5 ± 4.2 0.14
PASP (mmHg) 48 ± 14 54 ± 15 0.20
Pericardial effusion (n, %) 7 (8 %) 2 (14 %) 0.51
Pleural effusion (n, %) 19 (23 %) 5 (36 %) 0.42
B-lines at admission 43 ± 43 79 ± 66 0.01
B-lines at discharge 17 ± 22 40 ± 24 <0.0001
NYHA New York Heart Association, SAP systolic arterial pressure, CRP C-reactive
protein, TAPSE tricuspid annular plane systolic excursion, PASP pulmonary
artery systolic pressure
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Our data shows that patients with persistent sonographic
pulmonary congestion have an increased risk for rehospi-
talization for HF in the next 6 months, but the main find-
ing of our study is the very low risk of readmission in
patients with ≤ 15 B-lines before discharge. Thus, assess-
ment of B-lines would allow for tailored discharge risk
stratification. While further studies are needed, persistent
presence of B-lines may be useful to titrate therapy as well as
to personalize discharge planning and timing of follow-up.
It is interesting to note that although both B-lines at
admission and at discharge are predictors of rehospitaliza-
tion at univariate analysis, B-lines at discharge have a higher
Table 4 Univariate and multivariate analysis to predict events (HF readmission at 6 months)
Univariate analysis Multivariate analysis
HR (95 % CI) p HR (95 % CI) p
Age a 0.99 (0.95 – 1.04) 0.88
NYHA class a 2.31 (1.16 – 4.60) 0.017 1.48 (0.63 – 3.49) 0.37
Diabetes Mellitus 2.19 (0.76 – 6.31) 0.15
Creatinine a 1.58 (0.90 – 2.76) 0.11
Hemoglobin a 0.77 (0.59 – 1.02) 0.07
Hemoglobin < 10 g/dl 5.75 (1.76 – 18.78) 0.004 3.96 (0.52 – 30.10) 0.52
NT-proBNP at admission a 1.01 (0.99 – 1.01) 0.54
NT-proBNP at discharge a 1.01 (0.99 – 1.01) 0.55
NT-proBNP at discharge > 1635 ng/l 10.65 (1.35 – 84.26) 0.025 3.98 (0.43 – 37.18) 0.23
Ejection fraction a 1.01 (0.96 – 1.04) 0.91
Wall motion score index a 0.88 (0.35 – 2.17) 0.77
Restrictive pattern 0.33 (0.04 – 2.72) 0.30
TAPSE a 0.91 (0.80 – 1.03) 0.13
PASP a 1.03 (0.99 – 1.07) 0.11
Pericardial effusion (n, %) 1.68 (0.38 – 7.51) 0.49
Pleural effusion (n, %) 1.67 (0.51 – 5.49) 0.39
B-lines at admission a 1.01 (1.01 – 1.02) 0.004
B-lines at admission > 50 5.83 (1.82 – 18.62) 0.003 4.87 (0.88 – 27.06) 0.07
B-lines at discharge a 1.03 (1.01 – 1.04) 0.001
B-lines at discharge > 15 24.12 (3.15 – 184.55) 0.002 11.74 (1.30 – 106.16) 0.028
NYHA New York Heart Association, TAPSE tricuspid annular plane systolic excursion, PASP pulmonary artery systolic pressure, HR hazard ratio, CI confidence interval
a = continuous variable
Fig 3 Kaplan-Meier survival curves in HF patients stratified according to the number of B-lines before discharge, at 3-months follow-up
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hazard ratio and are the only independent predictors of
events at multivariate analysis. The best cut-offs obtained
by ROC analysis to maximize accuracy are also different: at
admission a higher number of B-lines is needed to confer
an increased risk of events at 6-months, compared to dis-
charge. This is reasonable, given the dynamic behavior of
B-lines that can be highly responsive to treatment [44], and
may rapidly change even after the short time of a dialysis
session [25, 45], or increase significantly during the few mi-
nutes of a stress-echo test [46].
The possibility to count B-lines has been debated in
the past. B-lines are substantially rough ultrasound arti-
facts, but by now many studies have shown the good
correlations between the somehow “imprecise” number
of B-lines and more established parameters of increased
EVLW and decompensation [15, 17, 24, 25, 47–52]. In
the clinical routine, however, the eyeballing imaging of
B-lines (the whiter the image under the pleural line, the
more B-lines) can be enough to get quick but meaning-
ful information on the degree of pulmonary congestion.
Moreover, the possibility to implement specific software
which may aid in establishing the severity of B-lines,
would further simplify the process [53].
We found > 15 and > 20 B-lines to be the best cut-offs
to maximize accuracy in the prediction of HF readmission
at 6 and 3 months. This cut-offs, although derived from
independent statistical analysis, are consistent with previ-
ous studies showing that ≥ 15 B lines predicts decompen-
sation in outpatients with HF [54]. It is worth noting
however, that counting B-lines should not be equated to a
precise assessment such as dosing a metabolite, and a dif-
ference in a few B-lines is not of clinical importance. The
spatial distribution of B-lines and not only the absolute
number of B-lines should be taken into account: first, it is
known that a few B-lines, especially at pulmonary bases,
can be found in normal subjects [13]; then, a very small
number of B-lines found in many different scanning sites,
although yielding an absolute high total number, may be
less clinically relevant than many B-lines in a smaller
number of scanning sites. As with any other test, B-lines
should not be interpreted in isolation, but integrated with
the overall clinical picture.
Despite not being a sophisticated, high tech parameter,
this simple ultrasound biomarker seems to effectively help
in the management of patients with HF, in a very sustain-
able and patient-friendly approach.
Limitations
This is a single-centre study with a relatively small study
group of patients with HF of different aetiologies. This
limitation however reflects the potentialities of LUS B-
lines in different clinical scenarios, including patients with
HF due to acute coronary syndromes. Given the relatively
small study population, the number of events is also low.
However, the number of patients enrolled was determined
as sufficient according to sample size calculation. It should
be emphasized that B-lines are a non-specific sign of pul-
monary interstitial syndrome, which can be found also in
interstitial pulmonary fibrosis, interstitial pneumonia and
acute respiratory distress syndrome. This is crucial espe-
cially when using B-lines for the differential diagnosis of
dyspnoea. When B-lines are used to determine persistent
pulmonary congestion in patients with an already estab-
lished diagnosis of HF, this limitation is less relevant.
Interpreting B-lines not as a single image, but in a specific
clinical context, is the key to avoid gross misinterpretation
of this sign. When presence or persistence of B-lines is
totally unrelated to the clinical picture, caution should be
used and other causes of B-lines should be taken into ac-
count (pulmonary fibrosis in patients on amiodarone, non
cardiogenic pulmonary edema, interstitial lung disease).
Persistent pulmonary congestion can be related to the
dosage of pharmacological therapy, especially diuretics;
unfortunately, we did not add the specific dosage of
therapies administered during hospital stay in our study
population. Our findings should be confirmed in a lar-
ger multicentre study.
Conclusions
In AHF patients, persistent pulmonary congestion as
defined by ≥ 15 B lines strongly predicts rehospitalization
in the following 6-months. Absence or a mild degree of
B-lines identify a subgroup at extremely low risk to be
readmitted for AHF. Sonographic B-lines can be useful
not only for the differential diagnosis of acute dyspnea,
but also for the prognostic stratification of HF patients.
Abbreviations
AHF: Acute heart failure; HF: Heart failure; LUS: Lung ultrasound; LV: Left
ventricle; EVLW: Extra-vascular lung water.
Competing interests
Peter Pang has been in the last 1 year a consultant for: Intersection Medical,
INSYS. Janssen, Medtronic, Novartis, Trevena, scPharmaceuticals, Cardioxyl,
Roche Diagnostics, Relypsa; honoraria: Palatin Technologies.
Authors’ contributions
EP and LG contributed to conception and design of the study. LG wrote the
draft manuscript. LG and FF performed the lung ultrasound assessments. FF
and PL collected all data. LG and MM performed the statistical analysis. PP,
MM and FLD participated in the study design and helped to draft the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
We are very thankful to Mr Gennaro D’Angelo and Miss Letizia Morelli for
their invaluable technical support.
Author details
1National Research Council of Pisa, Institute of Clinical Physiology, Via G.
Moruzzi, 1, 56124 Pisa, Italy. 2Department of Emergency Medicine, Indiana
University School of Medicine, Indianapolis, USA. 3Department of Emergency
Medicine, Azienda Ospedaliero-Universitaria, Pisa, Italy. 4Cardiology of Rio
Grande do Sul, Porto Alegre, Brazil. 5Cardiac, Vascular and Thoracic
Department, Azienda Ospedaliero-Universitaria, Pisa, Italy.
Gargani et al. Cardiovascular Ultrasound  (2015) 13:40 Page 7 of 9
Received: 25 July 2015 Accepted: 12 August 2015
References
1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart.
2007;93:1137–46.
2. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. ACCF/
AHA guideline for the management of heart failure: A report of the
american college of cardiology foundation/american heart association task
force on practice guidelines. Circulation. 2013;2013(128):240–327.
3. McMurray JJ V, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein
K, et al. ESC guidelines for the diagnosis and treatment of acute and
chronic heart failure 2012: the task force for the diagnosis and treatment of
acute and chronic heart failure 2012 of the european society of cardiology.
Developed in collaboration with the heart. Rev Port Cardiol.
2013;32:e1–641–e61.
4. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO.
Rehospitalization for heart failure. J Am Coll Cardiol. 2013;61:391–403.
5. Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JEA, Cleland JG,
et al. Assessing and grading congestion in acute heart failure: a scientific
statement from the acute heart failure committee of the heart failure
association of the European society of cardiology and endorsed by the
European society of intensive care medicine. Eur J Heart Fail.
2010;12:423–33.
6. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L.
SYstolic blood pressure at admission, clinical characteristics, and outcomes in
patients hospitalized with acute heart failure. JAMA. 2006;296:2217–26.
7. Gheorghiade M, Pang P, Ambrosy A, Lan G, Schmidt P, Filippatos G, et al. A
comprehensive, longitudinal description of the in-hospital and post-
discharge clinical, laboratory, and neurohormonal course of patients with
heart failure who die or are re-hospitalized within 90 days: analysis from the
EVEREST trial. Heart Fail Rev. 2012;17:485–509.
8. Picano E, Gargani L, Gheorghiade M. Why, when, and how to assess
pulmonary congestion in heart failure: pathophysiological, clinical, and
methodological implications. Heart Fail Rev. 2010;15:63–72.
9. Gheorghiade M, Shah AN, Vaduganathan M, Butler J, Bonow RO, Rosano GMC,
et al. Recognizing hospitalized heart failure as an entity and developing new
therapies to improve outcomes: academics’, clinicians’, industry’s, regulators’,
and payers’ perspectives. Heart Fail Clin. 2013;9:285–90. v–vi.
10. Gattis WA, O’Connor CM, Gallup DS, Hasselblad V, Gheorghiade M.
Predischarge initiation of carvedilol in patients hospitalized for
decompensated heart failure: results of the initiation management
predischarge: process for assessment of carvedilol therapy in heart failure
(IMPACT-HF) trial. J Am Coll Cardiol. 2004;43:1534–41.
11. Investigators TE, Coordinators ES. Evaluation study of congestive heart
failure and pulmonary artery catheterization effectiveness: The escape trial.
JAMA. 2005;294:1625–33.
12. Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick
AW, et al. International Liaison Committee on Lung Ultrasound (ILC-LUS) for
Interna tional Consensus Conference on Lung Ultrasound (ICC-LUS).
International evidence-based recommendations for point-of-care lung
ultrasound. Intensive Care Med. 2012;38:577–91.
13. Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc
Ultrasound. 2011;9:6.
14. Lichtenstein D, Mezière G. A lung ultrasound sign allowing bedside
distinction between pulmonary edema and COPD: the comet-tail artifact.
Intensive Care Med. 1998;24:1331–4.
15. Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E.
Ultrasound lung comets for the differential diagnosis of acute cardiogenic
dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail.
2008;10:70.
16. Prosen G, Klemen P, Štrnad M, Grmec S. Combination of lung ultrasound
(a comet-tail sign) and N-terminal pro-brain natriuretic peptide in
differentiating acute heart failure from chronic obstructive pulmonary
disease and asthma as cause of acute dyspnea in prehospital emergency
setting. Crit Care. 2011;15:R114.
17. Liteplo AS, Marill KA, Villen T, Miller RM, Murray AF, Croft PE, et al.
Emergency thoracic ultrasound in the differentiation of the etiology of
shortness of breath (ETUDES): sonographic B-lines and N-terminal
pro-brain-type natriuretic peptide in diagnosing congestive heart failure.
Acad Emerg Med. 2009;16:201–10.
18. Cibinel GA, Casoli G, Elia F, Padoan M, Pivetta E, Lupia E, et al. Diagnostic
accuracy and reproducibility of pleural and lung ultrasound in
discriminating cardiogenic causes of acute dyspnea in the Emergency
Department. Intern Emerg Med. 2012;7:65–70.
19. Ricci F, Aquilani R, Radico F, Bianco F, Dipace GG, Miniero E, et al. Role and
importance of ultrasound lung comets in acute cardiac care. Eur Hear J
Acute Cardiovasc Care. 2015;4(2):103–12.
20. Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E, et al. LUng ultrasound-
implemented diagnosis of acute decompensated heart failure in the
emergency department - a simeu multicenter study. Chest. 2015;148(1):202–10.
21. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S et al.
Recommendations on pre-hospital and early hospital management of acute
heart failure: a consensus paper from the Heart Failure Association of the
European Society of Cardiology, the European Society of Emergency
Medicine and the Society of Academic Emergency Medicine. Eur Heart J.
2015 Aug 7;36(30):1958–66.
22. Picano E, Frassi F, Gligorova S, Gargani L, Mottola G, Agricola E, et al.
Ultrasound lung comets: a clinically useful sign of extravascular lung water.
J Am Soc Echocardiogr. 2006;19:356–63.
23. Bedetti G, Gargani L, Corbisiero A, Frassi F, Poggianti E, Mottola G.
Evaluation of ultrasound lung comets by hand-held echocardiography.
Cardiovasc Ultrasound. 2006;4:34.
24. Jambrik Z, Monti S, Coppola V, Agricola E, Mottola G, Miniati M, et al.
Usefulness of ultrasound lung comets as a nonradiologic sign of
extravascular lung water. Am J Cardiol. 2004;93:1265–70.
25. Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, et al.
Detection of pulmonary congestion by chest ultrasound in dialysis patients.
JACC Cardiovasc Imaging. 2010;3:586–94.
26. Basso F, Milan Manani S, Cruz DN, Teixeira C, Brendolan A, Nalesso F, et al.
Comparison and reproducibility of techniques for fluid status assessment in
chronic hemodialysis patients. Cardiorenal Med. 2013;3:104–12.
27. Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J, Gheorghiade
M. The vulnerable phase after hospitalization for heart failure. Nat Rev
Cardiol. 2015;12:220–9.
28. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham
WT, et al. Characteristics and outcomes of patients hospitalized for heart
failure in the United States: Rationale, design, and preliminary observations
from the first 100,000 cases in the Acute Decompensated Heart Failure
National Registry (ADHERE). Am Heart J. 2005;149:209–16.
29. Desai AS, Stevenson LW. Rehospitalization for heart failure: Predict or
prevent? Circulation. 2012;126:501–6.
30. Zile MR, Bennett TD, St. John Sutton M, Cho YK, Adamson PB, Aaron MF,
et al. Transition from chronic compensated to acute d compensated heart
failure: Pathophysiological insights obtained from continuous monitoring of
intracardiac pressures. Circulation. 2008;118:1433–41.
31. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute
heart failure syndromes: an essential target of evaluation and treatment. Am
J Med. 2015;119:S3–10.
32. Volpicelli G, Skurzak S, Boero E, Carpinteri G, Tengattini M, Stefanone V, et al. Lung
ultrasound predicts well extravascular lung water but is of limited usefulness in
the prediction of wedge pressure. Anesthesiology. 2014;121(2):320–7.
33. Collins SP, Lindsell CJ, Storrow AB, Abraham WT. Prevalence of negative
chest radiography results in the emergency department patient with
decompensated heart failure. Ann Emerg Med. 2006;47:13–8.
34. Hummel SL, Ghalib HH, Ratz D, Koelling TM. Risk stratification for death and all-cause
hospitalization in heart failure clinic outpatients. Am Heart J. 2013;166:895–903. e1.
35. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ V, Swedberg KB, et al.
Predictors of mortality and morbidity in patients with chronic heart failure.
Eur Heart J. 2006;27:65–75.
36. Álvarez-García J, Ferrero-Gregori A, Puig T, Vázquez R, Delgado J, Pascual-Figal D,
Alonso-Pulpón L, González-Juanatey JR, Rivera M, Worner F, Bardají A, Cinca J.
Investigators of the Spanish Heart Failure Network (REDINSCOR). A simple
validated method for predicting the risk of hospitalization for worsening of heart
failure in ambulatory patients: the Redin-SCORE. Eur J Heart Fail. 2015;17(8):818–27.
37. Zoccali C, Torino C, Tripepi R, Tripepi G, D’Arrigo G, Postorino M, et al.
Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am
Soc Nephrol. 2013;24:639–46.
38. Siriopol D, Hogas S, Voroneanu L, Onofriescu M, Apetrii M, Oleniuc M, et al.
Predicting mortality in haemodialysis patients: A comparison between lung
ultrasonography, bioimpedance data and echocardiography parameters.
Nephrol Dial Transplant. 2013;28:2851–9.
Gargani et al. Cardiovascular Ultrasound  (2015) 13:40 Page 8 of 9
39. Gustafsson M, Alehagen U, Johansson P. Imaging Congestion With a Pocket
Ultrasound Device: Prognostic Implications in Patients With Chronic Heart
Failure. J Card Fail. 2015;21(7):548–54.
40. Frassi F, Gargani L, Tesorio P, Raciti M, Mottola G, Picano E. Prognostic value
of extravascular lung water assessed with ultrasound lung comets by chest
sonography in patients with dyspnea and/or chest pain. J Card Fail.
2007;13:830–5.
41. Bedetti G, Gargani L, Sicari R, Gianfaldoni ML, Molinaro S, Picano E.
Comparison of prognostic value of echocardiacgraphic risk score with the
Thrombolysis in Myocardial Infarction (TIMI) and Global Registry in Acute
Coronary Events (GRACE) risk scores in acute coronary syndrome. Am J
Cardiol. 2010;106(12):1709–16.
42. Neskovic AN, Hagendorff A, Lancellotti P, Guarracino F, Varga A, Cosyns B,
et al. Emergency echocardiography: the European Association of
Cardiovascular Imaging recommendations. Eur Hear J Cardiovascular
Imaging. 2013;14:1–11.
43. Lancellotti P, Price S, Edvardsen T, Cosyns B, Neskovic AN, Dulgheru R, et al.
The use of echocardiography in acute cardiovascular care: Recommendations
of the European Association of Cardiovascular Imaging and the Acute
Cardiovascular Care Association. Eur Hear J Acute Cardiovasc Care. 2015;4:3–5.
44. Volpicelli G, Melniker LA, Cardinale L, Lamorte A, Frascisco MF. Lung
ultrasound in diagnosing and monitoring pulmonary interstitial fluid. Radiol
Med. 2013;118:196–205.
45. Noble VE, Murray AF, Capp R, Sylvia-Reardon MH, Steele DJR, Liteplo A.
Ultrasound assessment for extravascular lung water in patients undergoing
hemodialysis. Time course for resolution. Chest. 2009;135:1433–9.
46. Agricola E, Picano E, Oppizzi M, Pisani M, Meris A, Fragasso G, et al.
Assessment of stress-induced pulmonary interstitial edema by chest
ultrasound during exercise echocardiography and its correlation with left
ventricular function. J Am Soc Echocardiogr. 2006;19:457–63.
47. Jambrik Z, Gargani L, Adamicza Á, Kaszaki J, Varga A, Forster T, et al. B-lines
quantify the lung water content: a lung ultrasound versus lung gravimetry
study in acute lung injury. Ultrasound Med Biol. 2010;36:2004–10.
48. Agricola E, Bove T, Oppizzi M, Marino G, Zangrillo A, Margonato A, et al.
“Ultrasound comet-tail images”: a marker of pulmonary edema: a
comparative study with wedge pressure and extravascular lung water.
Chest. 2005;127:1690–5.
49. Frassi F, Gargani L, Gligorova S, Ciampi Q, Mottola G, Picano E. Clinical and
echocardiographic determinants of ultrasound lung comets. Eur J
Echocardiogr. 2007;8:474.
50. Donadio C, Bozzoli L, Colombini E, Pisanu G, Ricchiuti G, Picano E, et al.
Effective and timely evaluation of pulmonary congestion: qualitative
comparison between lung ultrasound and thoracic bioelectrical impedance
in maintenance hemodialysis patients. Medicine (Baltimore). 2015;94:e473.
51. Gargani L, Picano E, Caramella D, Abramo A, Giunta F, Forfori F, et al. Lung
water assessment by lung ultrasonography in intensive care: a pilot study.
Intensive Care Med. 2013;39:74–84.
52. Pratali L, Cavana M, Sicari R, Picano E. Frequent subclinical high-altitude
pulmonary edema detected by chest sonography as ultrasound lung
comets in recreational climbers. Crit Care Med. 2010;38:1818–23.
53. Raso R, Gargani L, Tartarisco G, Pioggia G, Picano E. Operator-independent
soft computing-based assessment of extravascular lung water by
ultrasound. In: European Heart Journal. Volume 33. 2012. p. 404–5.
54. Miglioranza MH, Gargani L, Sant’anna RT, Rover MM, Martins VM, Mantovani
A, et al. Lung ultrasound for the evaluation of pulmonary congestion in
outpatients: a comparison with clinical assessment, natriuretic peptides, and
echocardiography. JACC Cardiovasc Imaging. 2013;6(11):1141–51.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Gargani et al. Cardiovascular Ultrasound  (2015) 13:40 Page 9 of 9
